Michael Bailey, MD
Clinical Cardiac Electrophysiology · Knoxville, TNNPI 1811926322
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (51.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 37 manufacturers reported payments, led by Biosense Webster, Inc. at 34.9% of the total. 2025 is the largest year on record at $10,662, 7.3 times the $1,457 reported in 2019.
Across 343 payments — averaging $79.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biosense Webster, Inc.$9K
- Medical Device Business Services, Inc.$6K
- Boston Scientific$5K
- Medtronic$3K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$689
- Atricure, Inc.$642
- plus $3K from 31 others
Across 6 payments — averaging $1695.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$10K
What the payments were for
- Consulting fees$13,87551%
- Travel & lodging$1,3745%
- Food & beverage$11,85144%
- Education$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biosense Webster, Inc. | 28 | $9,474 |
| Medical Device Business Services, Inc. | 5 | $5,625 |
| Boston Scientific | 105 | $4,913 |
| Medtronic(2 entities) | 45 | $3,084 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 43 | $689 |
| Atricure, Inc. | 19 | $642 |
| Impulse Dynamics (USA) Inc. | 6 | $530 |
| Abbott | 11 | $334 |
| Edwards Lifesciences | 10 | $298 |
| Pfizer | 10 | $160 |
| Cardiva Medical, Inc. | 7 | $129 |
| Kiniksa Pharmaceuticals International, PLC | 5 | $121 |
| Cvrx, Inc. | 1 | $116 |
| Sanofi-aventis U.S. LLC | 7 | $111 |
| Lundbeck LLC | 5 | $108 |
| Boehringer Ingelheim | 6 | $102 |
| Convatec Inc. | 1 | $87 |
| Inspire Medical Systems, Inc. | 2 | $67 |
| Johnson & Johnson | 4 | $54 |
| Amgen | 4 | $53 |
| Novo Nordisk | 1 | $46 |
| Braemar Manufacturing, LLC | 1 | $42 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $36 |
| Philips North America LLC | 1 | $34 |
| E.r. Squibb & Sons, L.L.C. | 2 | $32 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Medicomp Inc | 1 | $28 |
| Elutia, Inc. | 1 | $21 |
| Bardy Diagnostics, Inc. | 1 | $20 |
| Angiodynamics, Inc. | 1 | $20 |
| Catheter Precision Inc. | 1 | $20 |
| Scpharmaceuticals Inc. | 1 | $20 |
| Teleflex LLC | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $17 |
| Z-medica, LLC | 1 | $12 |
| AstraZeneca | 1 | $12 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$14,318
- Micra$1,278
- OPTIMIZER$646
- Watchman$229
- Carto 3 System$228
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$176
- AFFERA MAPPING SYSTEM$146
- WATCHMAN Access System$144
- SelectSecure$141
- RESONATE EL ICD VR$140
- ACCOLADE$134
- WATCHMAN FLX$131
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$125
- LATITUDE$125
- LUX-DX$122
- Barostim Neo System$116
- Amplia MRI$111
How this compares
$27,114 in reported general payments places this provider in the 65th percentile of 82 clinical cardiac electrophysiology providers in Tennessee.
See all clinical cardiac electrophysiology providers in Tennessee →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 66 | $62,385 |
| Flecainide Acetate | 61 | $1,686 |
| Droxidopa | 11 | $1,142 |
| Amiodarone Hcl | 68 | $889 |
| SotalolSotalol Hcl | 17 | $687 |
| Metoprolol Succinate | 52 | $455 |
| Nifedipine ErNifedipine | 11 | $71 |
| Metoprolol Tartrate | 15 | $53 |
| Benazepril Hcl | 12 | $51 |
| Furosemide | 19 | $39 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $160 | $62,38566 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 82 clinical cardiac electrophysiology providers in Tennessee.
Other clinical cardiac electrophysiology in Knoxville
- Jeffrey HirshKnoxville$36K
- Elliott GoodwinKnoxville$26K
- William MahlowKnoxville$21K
- James CoxKnoxville$21K
- Nilamkumar PatelKnoxville$17K
- Thomas WannenburgKnoxville$8K
- William LindsayKnoxville$4K
- Hitesh MehtaKnoxville$4K
- Stephen FahrigNashville$605K
- Gregory BashianNashville$361K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.